Ohio’s seed to sale process for producing medical marijuana. Michael Nyerges, Cincinnati Enquirer
Medical marijuana oils for vaping were pulled from the shelves this week after a labeling error was discovered by the Ohio State Board of Pharmacy.
It’s the first time state officials have halted sales of a product since medical marijuana sales began in mid-January.
A 1 milliliter syringe of marijuana concentrate made by Grow Ohio was sold as containing 590 milligrams of THC, or tetrahydrocannabinol, the main active ingredient in marijuana. But the label affixed to the product that shows testing lab levels incorrectly indicated the product had higher levels of THC.
Testing lab results can be up to 5 percent greater or less than what the product is advertised, according to state rules. The Grow Ohio test result label was off by more than 5 percent than the actual contents of the product, said Cameron McNamee, director of policy and communications for the pharmacy board.
Grow Ohio Executive Vice President Justin Hunt said the company was following state rules for calculating the total THC listed on the labels for marijuana-infused products. Hunt, a former state regulator in the program, said the pharmacy board had a different interpretation and they’ll fix the labels quickly,
The Ohio Department of Commerce put a hold on all sales of the oils Monday, affecting 851 units at 13 of the state’s 15 open dispensaries and product not yet shipped to stores. McNamee said the oil was not recalled because it was sold under the lower, actual amount of THC it contained.
“Patients don’t have to worry because they’re getting the dose that’s listed on the packaging,” McNamee said. “We were able to go back to